RESEARCH PAPER
Assessment of the incidence rate of end-stage renal disease in patients with and without diabetes in Poland
More details
Hide details
1
University of Humanities and Economics in Lodz, UHE Satellite Campus in Warsaw, Poland
2
Institute of Rural Health, Lublin, Poland
3
Medical University of Warsaw, Warsaw, Poland
4
National Health Fund, Central Office, Warsaw, Poland
Corresponding author
Waldemar Wierzba
University of Humanities and Economics in Lodz., ul. Nowoursynowska 160/1, 02-776 Warszawa, Poland
Ann Agric Environ Med. 2018;25(3):568-571
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Several studies have suggested, that diabetes is very important factor of the risk of the chronic a renal disease. The paper aims to present a retrospective analysis of incidence of end-stage renal disease in subgroups of patients with and without diabetes in Poland.
Material and methods:
For assessing this problem an electronic search was performed using Polish National Health Fund data base from 01.01.2011 until 31.12.2013 in general population and from 01.01.2012 until 31.12.2012 in 2 populations: with diabetes and without diabetes mellitus.
Results:
The 43.70 % patients with end-stage renal disease was diabetic. The incidence rate in 2012 was: 292.48 ± 90.97 diabetic men / 100,000 diabetic population; 203.10 ± 90.97 diabetic women / 100,000 diabetic population; 23.44 ± 6.34 non-diabetic men / 100,000 non-diabetic population; 17.88 ± 6.33 non-diabetic women / 100,000 non-diabetic population.
Conclusions:
The incidence rate of end-stage renal failure in diabetics was multiple times higher than the incidence rate in non-diabetics. The incidence rate of new ESRD cases in Poland estimated to be 36.17 per 100,000 of general populations in 2011, 35.28% in 2012 and 30.46 per 100,000 of general populations in 2013. In 2012, the incidence rate of new ESRD cases in male diabetics was 292.48 ± 90.97 per 100,000 of diabetes men population, and in women diabetics 203.10 ± 66.06 per 100,000 of diabetes women population. In the same 2012 year, the incidence of new ESRD cases in men non-diabetics was 3.44 ± 6.34 per 100,000 of non-diabetes, and in women non-diabetes 17.58 ± 6.33 per 100,000 of non-diabetes women population.
REFERENCES (22)
1.
Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385:1975–1982.
2.
Kdoqi Kdoqi. Chronic Kidney Disease Evaluation Classification. End Stratification 2012 http.//www.kidney.org/profesionals/kdoqi/guidelines/commentaries.cfn.
3.
Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One. 2016; DOI.10.1371/journal.pone.0158765.
4.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013; 382: 339–352.
5.
Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296–1305.
6.
Etgen T, Chonchol M, Förstl H et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol. 2012; 35: 474–482.
7.
Perlman RL, Finkelstein FO, Liu L i wsp. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005; 45: 658–666.
8.
Act of 27.08.2004 on health care services financed from public funds. (Journal of Laws 2008, no. 164, item 1027, as amended). Polish.9. Regulation of the Minister of Health of 11 January 2010 amending the regulation on guaranteed benefits in the field of health programs (Journal of Laws 2010 No. 05, item 29, as amended). Polish.
9.
Regulation of the Minister of Health of 2 March 2010 amending the regulation on guaranteed benefits in the field of hospital treatment (Journal of Laws of 2010, No. 30, item 157, as amended). Polish.
10.
Order No. 101/2007/DGL of the President of the National Health Fund dated 5 November 2007 amending the Order on the adoption of “Detailed information materials on proceedings concerning the conclusion of healthcare contracts and the implementation and financing of healthcare contracts Type: hospital treatment”. Polish.
11.
Order No. 36/2008/DGL of the President of the National Health Fund of 19 June 2008 on defining the conditions for concluding and implementing contracts such as hospital treatment in the field of therapeutic health programs. Polish.
13.
Chudek J, Wieczorkowska-Tobias K, Zejda J, et al. The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study PolSenior. Nephrol Dial Transplant. 2014; 29: 1073–1082.
14.
Rutkowski B, Król E. Epidemiology of chronic kidney disease in central and eastern Europe. Blood Purif. 2008; 26:381–385.
15.
O’Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGRF reporting. BMJ Open. 2011. DOI: 10.1136/bmjopen-2011–000308.
16.
Hommel K, Rasmussen S, Kamper AL, et al. Regional and social inequalities in chronic renal replacement therapy in Denmark. Nephrol Dial Transplant. 2010; 25: 2624–2632.
17.
de Francisco AL, De la Cruz JJ, Cases A, et al. Prevalence of kidney insufficiency in primary care population in Spain: EUROCAMP study. Nefrologia. 2007; 27: 300–312.
18.
National Kidney Fundation Kdoqi Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Diseases. Am J Kid Dis. 2007; 49: 1–80.
19.
US Renal Data System USRDS 2008 Annual Data Report Atlas of Chronic Kidney Disease And-Stage Renal Disease in the United States. Bethesda MB National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease 2008.
20.
Iseki K. Chronic kidney disease in Japan. Intern Med. 2008; 47: 681–689.
21.
United States Renal Data System 2015 ESROS Annual data report: Epidemiology of kidney disease in the United States National Institute of Health. National Institute of Diabetes and Digestive and Kidney Disease. Bethesda M. 2015.
22.
Incidence of end a stage renal disease related to diabetes mellitus (ESRD-DH) per 100,000 diabetes population United States 1980–2008.
http://www/cdc.gov/diabetes/st....